Concepedia
Publication | Open Access
Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial
579
Citations
36
References
2009
Year
NCT00274703.
Page 1